Drägerwerk stock holds after August 14 quote and PFAS headlines
Published on 08/17/2026 at 13:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Drägerwerk AG & Co. KGaA (DE0005550636) had a real-time valuation of EUR 109.50 on August 14, 2026, with a 0.00% five-day change and a +36.79% move for the year to date. The same source puts market cap at EUR 1,783 million for 2026, giving investors a fresh size and performance anchor.
PFAS debate adds a policy angle
Recent coverage on August 8, 2026, said Dräger sees hope for federal-government intervention on the PFAS ban, while an August 4, 2026 headline quoted the company warning that the chemical industry is dying quietly. Those two dated references frame the share debate around regulation rather than around a new earnings release.
For a medical and safety technology group, that matters because product demand and compliance costs can move together when industrial chemicals become a policy issue. The business profile also shows three operating regions - Europe, Americas, and Africa, Asia & Australia - which makes regulatory shifts relevant beyond Germany.
Valuation stays visible
The valuation page shows 2025 net sales of EUR 3,482 million, EBITDA of EUR 377.6 million, and EBIT of EUR 233.4 million. It also shows 2026 market-cap consensus at EUR 1,783 million, so the market is still pricing the company at a materially smaller equity value than annual revenue.
That comparison is useful for context because it puts the stock at 0.49x capitalization to revenue for 2026, while the 2025 P/E stands at 9.35x. Both figures point to a mid-single-digit operating multiple rather than a stretched one.
Business line
Drägerwerk sells medical and safety technology across hospital and industrial settings, with products spanning ventilation, monitoring, and personal protection equipment. The mix matters because hospital demand and workplace safety demand do not always move in sync.
Stock level
Drägerwerk stock traded at EUR 109.50 as of August 14, 2026, and the same snapshot showed a +36.79% gain for 2026. That leaves the name with a large year-to-date advance and a valuation page that still shows a 2026 market cap of EUR 1,783 million.
Fact box
Company: Drägerwerk AG & Co. KGaA
ISIN: DE0005550636
Ticker: 0K5E
Exchange: CBOE
Price (as of August 14, 2026, 11:30 a.m. ET): EUR 109.50
Market cap: EUR 1.783 billion
Sector / Industry: Advanced Medical Equipment & Technology
Index membership: SDAX
